Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this randomized controlled trial, neither a low nor high single dose of CBD directly reduced cortical excitability or produced measurable sedation in healthy adults. These findings suggest that CBD's well-documented anti-seizure…
endocannabinoid system clinical research: Cannabis for Back Pain
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks for chronic low back pain, with longer-term follow-up extending to one year. This…
`CBD Autism Trial: Endocannabinoid System Clinical Research`
Clinical Takeaway In this randomized controlled crossover trial, autistic children aged 5 to 12 received weight-based oral CBD oil at 10 mg/kg/day for 12 weeks, with outcomes measured across social relating, anxiety, and parental stress. The study used a…
`Cannabinoid Clinical Trials: CBD vs Placebo in Fibromyalgia`
Clinical Takeaway In this randomized controlled trial, CBD did not demonstrate superiority over placebo in reducing fibromyalgia pain. These findings highlight the current lack of robust clinical evidence supporting CBD as an effective treatment for…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trial
Clinical Takeaway This small randomized trial tested whether topical cannabis balms were feasible and tolerable for managing joint pain and stiffness caused by aromatase inhibitors in postmenopausal breast cancer patients. The study found that topical…
5 Surprising Benefits of Cannabidiol Anxiety Treatment
Exploring the Benefits and Safety of Nano-particle CBD for Anxiety Treatment What is this All About? Anxiety disorders are some of the most common mental health issues around the world. In 2019, about 301 million people were affected by these conditions.…